Learning Objectives:

  1. Understand recent updates in the diagnosis and management of HER2 low breast cancer
  2. Understand the role of adjuvant CDK 4/6 in high risk ER+ breast cancer
  3. Understand recent updates in the management of TNBC
Session date: 
11/11/2022 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Nan Chen, MD